INFORMATION FOR
News
Attila Feher, MD, PhD, has been selected for the American Society of Nuclear Cardiology (ASNC) Leadership Development Program.
Women's Health Research at Yale announces recipients of 2023 Pilot Project Program Grants
Twenty years after a study funded by Women's Health Research at Yale uncovered that women face the risk of poorer outcomes after heart bypass surgery, new research finds the increased risk for women persists despite improved overall outcomes. But, with increased representation of women in clinical research and innovation in targets of study, we can overcome the gender gap.
Carlos Mena-Hurtado, MD, was appointed to serve on the Society for Vascular Surgery Patient Safety Organization (SVS PSO) Governing Council.
Carlos Mena-Hurtado, MD, received a Clinical Coordinating Center Rally award for outstanding leadership in the CREST-2 trial.
John Spertus, MD, MPH, an expert on the measurement of quality of care and health status in cardiovascular disease, will speak at the virtual VAMOS Research Meeting on Tuesday, April 18.
When untreated, patients with Chagas disease are at risk for arrhythmias, dilated cardiomyopathy, or heart failure.
The Council on Peripheral Vascular Disease expert perspective provides interventions to improve PAD outcomes and patient satisfaction.
The Evolut Low-Risk Trial suggests that the initial benefit of TAVR remained consistent over the first three years
In the United States, a significant number of patients continue to struggle with persistent hypertension.
We are pleased to offer a robust and supportive educational training environment to foster research skill development in undergraduate researchers.
Yale provides cardiovascular risk assessment and treatment for patients with autoimmune diseases, including rheumatoid arthritis, systemic lupus, scleroderma, psoriatic arthritis, and vasculitis.
Makoto Mori, MD, PhD, and Harlan Krumholz, MD, SM, used a digital platform to collect patient-reported outcomes data after cardiac surgery.
The ACC Emerging Faculty Leadership Academy supports early-career academic cardiologists.
Rohan Khera, MD, MS, was selected for the ASCI Young Physician-Scientist Award.
Arya Mani, MD, outlined three recent discoveries from his lab.
Half of Medicare patients who underwent a procedure for symptom relief for peripheral vascular disease did not receive the recommended medical therapy for long-term cardiovascular risk management.
A recent study finds women and men's hearts are affected differently by exposure to the "fight or flight" hormone, noradrenaline. The difference in heart electrical activity may be a factor in arrhythmia susceptibility.
Aged bone marrow promotes the expansion of arterial smooth muscle cells and exacerbates the build-up of fatty deposits in artery walls, a new Yale study found.
Yale researchers have identified a potential target for the development of antihypertensive drugs.